|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 212 | Preferential Induction of Mucosal IgA Abs to the ELDKWA gp41 Epitope of HIV-1 following Parenteral Immunization in the Presence of the Pan DR Epitope
N. Decroix, C. P. Quan, and J.-P. Bouvet* INSERM, Paris, France |
| 213 | Identification of a Promiscuous HLA-DQ HIV Nef Peptide That Induces IFN- V. Pancré*1, B. Georges1, G. Angyalosi1, F. Castelli2, B. Maillère2, A. Bouzidi3, and C. Auriault1 1 IBL, Lille, France; 2 CEA, Gif sur Yvette, France; and 3Sedac Therapeutics, Lille, France |
| 214 | Peptide Sequences Mimicking the C1 Region of gp120 as Potential Inducers of Antibody-Dependent Cellular Cytotoxicity (ADCC)
V. R. Gómez-Román*1, K. Ugen2, C. Cao2, K. Manoutcharian1, and G. Gevorkian1 1Inst. de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México and 2Univ. of South Florida Coll. of Med., Tampa, USA |
| 215 | C Clade HGP-30 (p17 aa 86(115)-Based Peptide Conjugates as Potential Therapeutic and Prophylactic HIV-1 Vaccine Antigens
M. Siwek, D. Winship, M. Manner, and D. Zimmerman*, CEL-SCI Corp., Vienna, VA, USA |
| 216 | Affinity of the HIV-Neutralizing Monoclonal Antibody 2F5 for GP41 ELDKWA Analogues
Y. Tian1, C. V. Ramesh1, X. Ma1,2, T. Patel1, M. Tiscione1, T. Cenizal1, K. Diaz1, T. Crea1, J. W. Taylor*1, G. F. Arnold1,2, and E. Arnold1,2 1Rutgers Univ., Piscataway, NJ, USA and 2Ctr. for Advanced Biotechnology and Med., Piscataway, NJ, USA |